stockrow
Monday 9 November 2026
Export IFRX’s income statement to Excel — free account
InflaRx N.V.
IFRXInflaRx N.V.’s revenue for fiscal 2025 (year ended December 2025) was $33,200.00, down 81.5% from fiscal 2024.
- Revenue
- −128.9%
- EPS
- +90.9%
- Free cash flow
- +59.8%
Quarter to September 2026, against a year earlier
1.31
0.05
−3.68%
Follow IFRX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | — | — |
P/S ratio |
2,220.94 | — | — | — | |
P/FCF ratio |
0.00 | — | — | — | |
P/Operating CF |
(16.27) | — | — | — | |
P/B ratio |
1.45 | — | — | — | |
Price to Tangible BV |
1.45 | — | — | — | |
EV/Sales |
411.26 | — | — | — | |
EV/EBITDA |
0.00 | — | — | — | |
EV/Operating CF |
(0.31) | — | — | — | |
EV/FCF |
(0.31) | — | — | — | |
Quick Ratio |
3.88 | 3.88 | 8.10 | 7.19 | |
Current Ratio |
4.13 | 4.16 | 8.22 | 7.26 | |
Net Debt/EBITDA |
3.28 | 5.77 | 22.35 | 20.72 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.34 | 1.32 | 0.24 | 1.61 | |
Capex/Depreciation |
0.02 | (0.11) | (0.50) | (0.65) | |
Interest Coverage |
(870.88) | (504.43) | (500.48) | (412.78) | |
Research and Development Expense of Revenue |
(15,830.20%) | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
(10,522.34%) | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
(349.24%) | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.67 | — | — | — | |
Graham Number |
0.00 | — | — | — | |
Earnings Yield |
(75.25%) | — | — | — | |
Free Cash Flow Yield |
(59.16%) | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.06) | (0.12) | (0.02) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.06) | (0.12) | (0.03) | (0.03) | |
Cash per Share |
0.82 | 0.69 | 1.60 | 0.93 | |
Shareholders Equity per Share |
0.70 | 0.60 | 1.44 | 1.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.70 | 0.60 | 1.44 | 1.13 | |
Free Cash Flow |
(4.17) | (8.66) | (2.99) | (4.59) | |
Working Capital |
45.99 | 42.14 | 168.90 | 120.08 | |
Capital Expenditures |
0.00 | (0.01) | (0.05) | (0.06) | |
Net Current Asset Value |
45.23 | 41.43 | 168.21 | 119.44 | |
EV/EBIT |
0.00 | — | — | — | |
Capex to Sales |
0.05 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | — | — | — | |
| Other line items | |||||
Average Receivables |
1.75 | 1.86 | 1.90 | 1.80 | |
Average Payables |
9.22 | 7.24 | 8.61 | 7.74 | |
Average Assets |
72.37 | 74.44 | 138.72 | 130.92 | |
Average Common Equity |
56.74 | 58.71 | 117.36 | 109.45 |
Columns are period end dates · fundamentals updated 5 Nov 2026